title: Not all sulfa drugs are created equal.
authors.affiliation: Safety and Risk Management, Pfizer Global Research and Development, Pfizer Inc., 50 Pequot Ave. (6025-B4231), New London, CT 06320-5410, USA. steven_m_toler@groton.pfizer.com
authors.forename: Steven M
authors.initials: SM
authors.lastname: Toler
authors.forename: Ignacio
authors.initials: I
authors.lastname: Rodriguez
mesh_terms: D018712:Analgesics, Non-Narcotic / Q000009:adverse effects / Q000737:chemistry; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000737:chemistry; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000009:adverse effects / Q000737:chemistry; D004347:Drug Interactions; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000737:chemistry; D013329:Structure-Activity Relationship; D013449:Sulfonamides / Q000009:adverse effects / Q000737:chemistry* / Q000145:classification*
chemical_list: D018712:Analgesics, Non-Narcotic; D000890:Anti-Infective Agents; D004232:Diuretics; D007004:Hypoglycemic Agents; D013449:Sulfonamides